Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
Heppt MV, Siepmann T, Engel J, Schubert-Fritschle G, Eckel R, Mirlach L, Kirchner T, Jung A, Gesierich A, Ruzicka T, Flaig MJ, Berking C.
Heppt MV, et al. Among authors: ruzicka t.
BMC Cancer. 2017 Aug 10;17(1):536. doi: 10.1186/s12885-017-3529-5.
BMC Cancer. 2017.
PMID: 28797232
Free PMC article.